Exceptional Clinical Research for Skin Care Innovation

40+ years of expertise | 100+ protocols annually | Regulatory-ready results

Why Choose KGL?

KGL Skin Study Center has been the trusted partner for pharmaceutical companies, cosmetic brands, and personal care product manufacturers since 1984. Our unique combination of speed, reliabilty, and expertise makes us the preferred choice for clinical research in skin care.

Credibility & Compliance
Expertise & Technology
Speed & Efficiency

Founded in 1984 by clinical pioneers Kays H. Kaidbey, MD, Gary L. Grove, PhD, and James J. Leyden, MD, our center is built on a foundation of academic and scientific excellence. We are fully GCP compliant, maintaining an internal standard of excellence you can rely on. Furthermore, we provide regulatory-ready documentation and submission support that is recognized and accepted by agencies worldwide.

Our research is led by board-certified dermatologists Dr Omer Ibrahim, MD, MBA and Dr Stuart Lessin, MD, supported by the industry-leading instrumental expertise of Tim Houser, MS. We utilize advanced technology and automated systems to maintain the highest levels of efficiency and data quality. With decades of experience, we deliver proven endpoints and validation data that support reliable, reproducible results for our partners.

KGL Skin Study Center ensures rapid study activation by leveraging a massive volunteer database, along with online and radio campaigns to rapidly enroll your studies with a diverse selection of participants located within 15 minutes of the Philadelphia area. We provide a block enrollment guarantee to ensure timely study initiation, while our use of electronic IRB submissions significantly reduces administrative delays. With over 100 protocols executed annually, our team demonstrates a proven track record of capacity and on-time delivery for every project.

Our Research Services

Claims Substantiation​

Our robust clinical research approach incorporates Dermatologist assessed clinical outcomes, advanced photography and analysis, industry leading instrumental approaches, and thoughtful consumer understanding protocols to support claims substantiations for cosmetic, consumer products, over-the-counter and prescription drugs and devices for the skin and hair.

  • Noncomedogenic / Non-Acnegenic
  • Anti-Inflammatory
  • Anti-Itch
Safety Patch Testing

KGL conducts a variety of repeat insult patch testing (RIPT) for assessing safety and tolerability for use on human skin. Many of which were developed by the founder of KGL, Dr. Albert M. Kligman. These types of studies remain the industry standard for new ingredient and product testing:

  • Allergenicity
  • Photosensitivity
  • Irritancy
  • Acnegenicity/Comedogenicity
  • Pruritus
  • Cell Turnover
 
Clinical Trials (Phase II – IV)

KGL’s large database and board-certified medical specialists makes us well suited for conducting phase II through IV clinical trials in diverse populations and study types

  • Aging Skin
  • Eczema/Atopic Dermatitis
  • Acne
  • Rosacea
  • Psoriasis
  • Vitiligo
  • Warts /Molluscum
  • Aesthetic Devices and Injectables
 
Proof of Concept Studies

Small studies to demonstrate efficacy and/or safety prior to large scale testing are often useful starting points in commercial development. KGL has experience in designing and conducting proof of concept studies for a wide array of indications with both novel and customizable endpoints. Skin biopsy tissue acquisition provides analysis for:

  • Histology
  • Immunohistochemistry
  • DNA, RNA, Protein
  • Microbiology
 

Our Process: Design to Delivery

We manage every aspect of your clinical study from initial concept through final reporting.

Phase I: Design & Development

We work closely with you to design studies that meet your specific research objectives and regulatory requirements. Our team brings decades of experience to ensure your study is positioned for success from day one.

Concept and Trial Design

Protocol Development

Informed Consent Form Development

Budgeting

Phase II: Study Conduct & Management

Our experienced team manages every operational detail of your study, from regulatory submissions through final data delivery. We leverage advanced technology and rigorous quality control to ensure reliable, audit-ready results.

Electronic IRB Submissions

Rapid Recruitment

Block Enrollment

Qualified Professional & Support Staff

Reliable Endpoints

Quality Data Capture processing and analysis

Adverse Events Management and Reporting

Product Accountability

comprehensive Results Reporting with statistical anaysis

How To Get Started

Your Path to Partnering with KGL:

Ready to Begin Your Research?​

Partner with KGL for reliable, compliant clinical testing backed by 40 years of expertise.

Hi there! We are currently updating our branding and website to better serve you.

If you are here for our Dermatitis Research Study, please click the button below for more information.